Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 1691-1700 Newer>

Bio-IT World January 21, 2005 Salvatore Salamone	Tackling the Biobank Data Challenge To be successful, biobanks must ensure that the information they collect gets maximum use by others. A host of legal, financial, and intellectual property issues must be addressed from the beginning.
Bio-IT World January 21, 2005 Mark D. Uehling	Breeding Mice That Roar Taconic Farms, a leading purveyor of laboratory animals, has built a $10-million facility in Cambridge City, Ind. which will allow express shipping of rats and mice to Midwestern science hubs.
Bio-IT World January 21, 2005 Robert M. Frederickson	High-Throughput Science Although genomic assays led the charge toward high-throughput science, new detection systems and formats are enabling the application of high-throughput techniques to proteins and cells.
Bio-IT World January 21, 2005	The Race Prescription Card The FDA is on the verge of approving a heart disease drug called BiDil that is particularly effective in African-Americans. Some see this as a an effort to address health inequalities while others view it as a first step en route to racial discrimination.
Bio-IT World January 21, 2005	Best Practices 2005: Strut Your Stuff Organizations are invited to strut their stuff for Bio*IT World's annual awards program.
The Motley Fool January 21, 2005 W.D. Crotty	CNS Strips for Profits Nasal strip sales soar, and so do the company's third-quarter profits.
The Motley Fool January 21, 2005 Stephen D. Simpson	Kensey's Guidance Falls Just Short Small-cap medical device maker posts an "OK" quarter when the market wants "great."
The Motley Fool January 21, 2005 Charly Travers	Seeing the Value in QLT A narrow-minded market could be creating a great drug value.
The Motley Fool January 21, 2005 Rich Duprey	Cardinal Back in the Nest Drug distributor and Japanese pharma Eisai come to agreement after all.
BusinessWeek January 31, 2005 Arlene Weintraub	Chiron's Flu Aches May Last Awhile Its vaccine rivals are gaining traction -- and its other businesses are just so-so
<Older 1691-1700 Newer> Return to current articles.